Clinical updates, including trial initiations, enrollment status and data readouts and publications: Natera, Neurometrix, Sherlock Biosciences.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arch, Astrazeneca, Athenex, BMS, GSK, Inmune, Mirum, Nkmax, Novo, Plus, Vertex.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aegis, Altimmune, Altum, Antios, Applied Biomath, Aptorum, Astellas, Astrazeneca, Bavarian Nordic, Betterlife, Boston Pharmaceuticals, Daré, Dcprime, Domain, Elix, Elixirgen, Emergex, Entos, Flame, Glaxosmithkline, HDT Bio, Humanigen, Immpronano, Immunobrain, Medicinova, Mirum, Neuclone, Northwest Biotherapeutics, Novartis, Oxford Biomedica, PCI, Pfizer, Recce, Relation Therapeutics, Revision, Rodeo, Sonnet, Tavanta.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alimera, Annovis, Aptevo, Arena, Astrazeneca, Biophytis, BMS, Cartesian, Clear Creek, Genfit, Hepion, Immunomic, Innovent, Iveric, Kuros, Orchard, Oxurion, Sanofi, Transcenta.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agex, Arrakis, Bharat, Biocryst, Cheplapharm, Elektrofi, Glycomimetics, Immutep, Kalos, Leo, Ligand, Lineage, Maat, Metagenomi, Mindset, Novavax, PDL, Qualigen, Resverlogix, Regulus, Sanofi, Seneca, Sotio, Unum, Vallaurix, Vor.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: The International Contrast Ultrasound Society.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Coghlin Companies, Cogmedix, Concord Medical, Dominion Aesthetics, Formsense, Genesis Medtech, Nowdiagnostics, Ontrak, Todos Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acasti, Akari, Axsome, Bluebird, Eiger, Embera, GSK, Imbrium, Kiadis, Maat, Mirum, NGM, Novan, Novartis, Orpheris, Provention, Regenerx, Shattuck, VBI, Vir.

The latest global regulatory news, changes and updates affecting biopharma.